Open Access
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(01): 085-098
DOI: 10.1055/s-0042-1749218
Presentation Abstracts

A Prospective Evaluation of a Decade Follow-up Period in Patients with Knee-Activated Osteoarthritis Treated with Yttrium-90 Radiation Synovectomy

Ioannis Iakovou
1   Department of Nuclear Medicine, Aristotle University, AHEPA HSP, Thessaloniki, Greece
,
Georgia Koutsouki
2   Aristotle University, School of Medicine, Thessaloniki, Greece
,
Evanthia Giannoula
1   Department of Nuclear Medicine, Aristotle University, AHEPA HSP, Thessaloniki, Greece
,
Argirios Doumas
1   Department of Nuclear Medicine, Aristotle University, AHEPA HSP, Thessaloniki, Greece
,
Emmanouil Papanastasiou
1   Department of Nuclear Medicine, Aristotle University, AHEPA HSP, Thessaloniki, Greece
,
Michail Potoupnis
3   Third Department of Orthopedics, Aristotle University, Papageorgiou HSP, Thessaloniki, Greece
› Institutsangaben
 
  • Areas of Interest: Pain

Aim: This study aimed to assess the outcome of yttrium-90 radiation synovectomy (RS) in patients with knee activated osteoarthritis in a decade follow-up period.

Methods: We prospectively evaluated 52 patients, aged 64 years (42–86 years) of age, with osteoarthritic (Kellgreen–Lawrence grades I–III) knee pain resistant to conventional therapy referred for intraarticular yttrium-90 treatment in 2011, due to synovial inflammation, as demonstrated by early-phase bone scintigraphy. All patients were offered a long-term follow-up to almost a decade after initial treatment at 6, 12, and 60 months and then every year up to 120 months (only 12/52 patients finally managed to fully participate). Treatment outcome was evaluated by assessing the variation of a composite index (CCi) calculated in terms of a patient subjective visual analogue scale (VAS) reporting knee pain in combination with a scoring system of objective clinical and functional parameters at rest and under load (joint edema/hyperthermia, pain in load, flexion, ability to walk, intra-articular therapies after RSO, and knee surgery), ranging from 0 (no change–worsening) to 35 (excellent response).

Results: After first RSO, 21 patients underwent no other intra-articular treatment, with a range of 1 to 6 knee punctures for the rest of patients. The overall response rate for all treated joints was 65% at 12 months and 54% at 120 months (p = not significant). The mean improvement rate for early stage (Kellgreen–Lawrence grade I/II) treated joints was higher than the one achieved by all patients in total.

Conclusion: Yttrium-90 radiation synovectomy exerts a beneficial therapeutic effect in patients suffering of knee synovial inflammation due to osteoarthritis. Long-term results are excellent/good in many patients, almost 10 years after initial therapy, with better results succeeded in the cases of radiological minimal changes (early Kellgreen–Lawrence stage).



Publikationsverlauf

Artikel online veröffentlicht:
10. Mai 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India